Sheepish about social networking 

Flickr photo by pasotraspaso.

I was reading this morning about a new obesity drug that has Wall Street analysts gravely disappointed. It seems that after years of clinical trials, the drug passed two of three important tests with flying colors. It helped lower cholesterol and, if that wasn't enough, it didn't appear to cause heart-valve failure. It sounds like a winner so far.

The one test it failed, however, was a doozy. The weight-loss drug did not result in people actually losing weight.

more...

To view this premium content sign in to your Premium Member account.

Premium Members have full access to all news archives & premium content.

Purchase Premium+ Membership for $99/year OR
Premium Membership for $49/year

Buy Now

Advertise with Inman

All rights reserved. This article may not be used or reproduced in any manner whatsoever, in part or in whole, without written permission of Inman News. Use of this article without permission is a violation of federal copyright law.